Simon Tarsh
Financieel Directeur/CFO bij RENOVARO INC.
Vermogen: - $ op 30-04-2024
Profiel
Simon Tarsh is currently a Senior Managing Director-Finance Enterprise at Deloitte Consulting LP since 2007.
He is also an Independent Director at Onconetix, Inc. since 2022 and the Chief Financial Officer at Renovaro, Inc. since 2024.
Previously, he served as an Independent Director at Blue Water Biotech, Inc. Mr. Tarsh obtained his undergraduate degree from the University of Salford in 1981 and an MBA from Bayes Business School in 1988.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ONCONETIX INC
-.--% | 05-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
RENOVARO INC.
-.--% | 11-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Simon Tarsh
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCONETIX, INC. | Directeur/Bestuurslid | 01-08-2022 |
| RENOVARO INC. | Financieel Directeur/CFO | 11-03-2024 |
Deloitte Consulting LP
 Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Corporate Officer/Principal | 01-01-2007 |
Eerdere bekende functies van Simon Tarsh
| Bedrijven | Functie | Einde |
|---|---|---|
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Directeur/Bestuurslid | - |
Opleiding van Simon Tarsh
| University of Salford | Undergraduate Degree |
| Bayes Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| RENOVARO INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
Deloitte Consulting LP
Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Commercial Services |